A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary CholangitisFrederik Nevens, Д. А. Шапиро, Michael Trauner et al.|New England Journal of Medicine|2016Cited by 1.1k
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV InfectionMarc Bourlière, Stefan Zeuzem, Stuart C. Gordon et al.|New England Journal of Medicine|2017Cited by 565
Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis CM. Colombo, Heiner Wedemeyer, Inmaculada Fernández et al.|Gut|2013Cited by 46
Sustained virological response with telaprevir in 1078 patients with advanced hepatitis C: The international telaprevir access programMassimo Colombo, Heiner Wedemeyer, Simone I. Strasser et al.|Journal of Hepatology|2014Cited by 29
Five‐year efficacy and safety of tenofovir‐based salvage therapy for patients with chronic hepatitis B who previously failed <scp>LAM</scp>/<scp>ADV</scp> therapyLucy Lim, Peter Angus, Alexander Thompson et al.|Liver International|2016Cited by 14